Today’s article highlights two clinical-stage biopharmaceutical stocks that analysts expect to more than double in the coming months — one engaged in discovering and developing…
Avoid the market’s most volatile stocks, advises the author of today’s article. In fact, he refers to the market’s top 10% or top 20% most…
“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than…
What stocks are Wall Street’s best-performing analysts most bullish on right now? One service has identified the Street’s top analysts (based on the average return…